n-methylaspartate has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Asano, D; Hayashi, I; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K; Ushikubo, H | 1 |
| Abais, JM; Boini, KM; Brimson, CA; Laperle, LA; Li, PL; Xia, M; Yi, F; Zhang, C; Zhu, Q | 1 |
| Craver, RD; Leung, JC; Marphis, T; Silverstein, DM | 1 |
3 other study(ies) available for n-methylaspartate and Kidney Diseases
| Article | Year |
|---|---|
Protective effects of PF-4708671 against N-methyl-d-aspartic acid-induced retinal damage in rats.
Topics: Animals; Calcium-Binding Proteins; Imidazoles; Kidney Diseases; Leukocyte Common Antigens; Leukocytes; Male; Microfilament Proteins; Microglia; N-Methylaspartate; Neuroprotective Agents; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Sirolimus | 2016 |
NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats.
Topics: Animals; Cell Line; Dizocilpine Maleate; Extracellular Matrix; Folic Acid; Gene Expression; Hyperhomocysteinemia; Kidney; Kidney Diseases; Kidney Glomerulus; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; N-Methylaspartate; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tissue Inhibitor of Metalloproteinase-1 | 2010 |
Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist.
Topics: Animals; Anti-Bacterial Agents; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Gentamicins; Intracellular Membranes; Kidney; Kidney Diseases; Male; N-Methylaspartate; Nitrites; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 2004 |